Evaluation of Compliance Issues to Anti-glaucoma Medications Before and After a Structured Interventional Program

Abstract

BackgroundGlaucoma is one of the most common eye diseases in the elderly and the major cause of irreversible vision loss worldwide. Adherence to life-long therapies is crucial to prevent glaucoma progression. The current study aims to assess the educational element and its impact on glaucoma medication compliance over short and long periods. MethodsThis was a survey-based, prospective, interventional study, conducted via interviews of all glaucoma patients presented to the Ophthalmology Center at King Abdullah Medical City (KAMC), Makkah, Saudi Arabia. To achieve the study's aim, a questionnaire with 31 items was utilized, followed by a structured program between September 2019 to June 2021. After that, a second questionnaire was used after a one month to one year to re-evaluate the intervention.

Glaucoma among Saudi Arabian population: a scoping review

“…All the included studies [1,[8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] were conducted between the years 2011 and 2022, with most of them in the few recent years. Most studies were conducted in Riyadh (n=11), followed by Jeddah (n=4).…”

“…The authors found that nearly half of the participants thought the patients could not be aware of their glaucoma from the symptoms. In comparison, Subhan et al [26] explored the effects of a structured interventional program on the compliance of glaucoma patients to anti-glaucoma medications. The authors noticed a significant improvement in the patient's compliance from 84.3% to 92.5%.…”